Product Pathways
BCP0293 Naratriptan(Amerge)
Naratriptan (Amerge) is a triptan agent that is used for the treatment of migraine headaches.
BCP0146 SL650155
SL65.0155, a serotonin 5-HT4 receptor partial agonist, in male rats of the Wistar strain tested in the forced swim test (FST), an experimental model widely used to assess antidepressant-like activity.
BCP0394 Agomelatine
Agomelatine is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor.
BCP0408 Asenapine
Asenapine (Saphris) is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder.
BCP0440 Flibanserin(BIMT 17)
A 5-HT1A receptor full agonist with 5-HT2A receptor antagonistic activity.
BCP0457 Rizatriptan Benzoate(Maxalt)
Rizatriptan Benzoate(Maxalt) is a 5-HT1 agonist triptan drug for the treatment of migraine headaches.
BCP0491 Prucalopride
Prucalopride is a potent 5-HT4 receptor inhibitor with IC50 of 2.5 nM.
BCP0497 SB 699551
Selective 5-HT5A receptor antagonist.
BCP0500 Granisetron hydrochloride
5-HT3 receptor antagonist that possesses potent antiemetic activity.
BCP0501 Ketanserin
Ketanserin (Vulketan Gel) is specific 5-HT2A serotonin receptor antagonist with a Ki of 2.5 nM for rat and human 5-HT2A.
第一页 1 2 3 4 5 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.